Photo of Vivien Prise
  • Room 02.023 - H.S.B

    United Kingdom

20122016

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Vivien Prise is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Lipoprotein-associated phospholipase A2 (Lp-PLA2) as a therapeutic target to prevent retinal vasopermeability during diabetes

Canning, P., Kenny, B-A., Prise, V., Glenn, J., Sarker, M. H., Hudson, N., Brandt, M., Lopez, F. J., Gale, D., Luthert, P. J., Adamson, P., Turowski, P. & Stitt, A. W., 28 Jun 2016, In : Proceedings of the National Academy of Sciences of the United States of America. 113, 26, p. 7213-7218 6 p.

Research output: Contribution to journalArticle

Open Access
File
  • 29 Citations (Scopus)
    222 Downloads (Pure)

    The pathogenic role of lipoprotein phospholipase A2 (Lp-PLA2) in diabetic retinopathy

    McAllister, K., Canning, P., Adamson, P., Prise, V. & Stitt, A., Apr 2015.

    Research output: Contribution to conferenceAbstract

    Lp-PLA 2 is a potential therapeutic target in diabetic macula edema

    Canning, P., Glenn, J., Prise, V., Gale, D., Adamson, P. & Stitt, A., 2013, p. 4613.

    Research output: Contribution to conferenceAbstract

    Lipoprotein-associated Phospholipase Inhibition Regulates Retinal Vasopermeability During Experimental Diabetes

    Stitt, A., Canning, P., Luthert, P., Glenn, J., Allen, L-D., Prise, V. & Adamson, P., 2012, p. 5765.

    Research output: Contribution to conferenceAbstract